One aspect that deserves attention is that all our studies are carried out in immunocompromised settings, and given that recent reports have suggested that CD8+ T‐Cells can drive tumor regression partially via ferroptosis (Matsushita et al, 2015; Liao et al, 2022) the effects observed here might be to some extent underestimated. This evidence concerns the gene CD8A and neoplasm.